|
ZNF711 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.207800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.341800E-01 |
| Normal-vs-Stage2 |
9.266400E-01 |
| Normal-vs-Stage3 |
1.201580E-01 |
| Normal-vs-Stage4 |
6.923800E-03 |
| Stage1-vs-Stage2 |
9.851400E-01 |
| Stage1-vs-Stage3 |
8.218300E-02 |
| Stage1-vs-Stage4 |
6.117100E-03 |
| Stage2-vs-Stage3 |
3.137800E-01 |
| Stage2-vs-Stage4 |
7.766000E-02 |
| Stage3-vs-Stage4 |
2.526400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.591800E-01 |
| Normal-vs-AfricanAmerican |
8.512600E-01 |
| Normal-vs-Asian |
7.729400E-01 |
| Caucasian-vs-AfricanAmerican |
4.121400E-01 |
| Caucasian-vs-Asian |
9.555400E-01 |
| AfricanAmerican-vs-Asian |
6.764000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.564910E-03 |
| Normal-vs-Female |
1.434420E-02 |
| Male-vs-Female |
3.33820000530949E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.527990E-01 |
| Normal-vs-Age(41-60Yrs) |
8.930200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.323610E-01 |
| Normal-vs-Age(81-100Yrs) |
7.992000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.195800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.430000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.403000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.843980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.517600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.438000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.201100E-03 |
| Normal-vs-Grade 2 |
2.647000E-01 |
| Normal-vs-Grade 3 |
1.165020E-01 |
| Normal-vs-Grade 4 |
8.92039997424376E-09 |
| Grade 1-vs-Grade 2 |
1.849580E-02 |
| Grade 1-vs-Grade 3 |
7.82249999999873E-05 |
| Grade 1-vs-Grade 4 |
1.392700E-04 |
| Grade 2-vs-Grade 3 |
8.762600E-03 |
| Grade 2-vs-Grade 4 |
6.24640339452753E-11 |
| Grade 3-vs-Grade 4 |
2.55110000002556E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.92930000000513E-05 |
| Normal-vs-ccB subtype |
1.14900000625084E-09 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.054200E-01 |
| Normal-vs-N1 |
6.63829999969501E-07 |
| N0-vs-N1 |
2.19499999953854E-07 |
|
|
